SENEB:NASDAQSeneca Foods Corp. Analysis
Data as of 2026-06-12 - not real-time
$145.75
Latest Price
4/10Risk
Risk Level: Medium
Executive Summary
Seneca Foods (SENEB) trades at $145.75, well below its DCF-derived fair value of $268, indicating a substantial upside potential. The stock benefits from a low beta (~0.02) and a moderate 30‑day volatility of 12%, suggesting limited market risk but some price swings. Fundamentals are solid: $1.61 B in revenue with modest 1.1% growth, healthy operating margins (~12.3%), ROE of 13.6% and a reasonable debt‑to‑equity ratio of 41%. Cash generation is strong, with $33 M cash on hand, $152 M free cash flow and a price‑to‑book of 1.39. Technicals show a bullish MACD crossover and price above the 20‑ and 50‑day SMAs, yet the RSI of 66 hints at short‑term overbought conditions and volume is decreasing, raising liquidity concerns.
The recent quarterly earnings release confirmed stable earnings and margins, reinforcing the defensive nature of the business. With no dividend, the appeal lies in value appreciation rather than income. Given the defensive consumer sector, low regulatory exposure, and international diversification, the stock presents a compelling long‑term buy at current levels, while short‑term traders may prefer to hold pending a clearer breakout or pull‑back.
The recent quarterly earnings release confirmed stable earnings and margins, reinforcing the defensive nature of the business. With no dividend, the appeal lies in value appreciation rather than income. Given the defensive consumer sector, low regulatory exposure, and international diversification, the stock presents a compelling long‑term buy at current levels, while short‑term traders may prefer to hold pending a clearer breakout or pull‑back.
Market Outlook
Short Term
< 1 yearNeutral
Model confidence: 5/10
Key Factors
- Bullish MACD but RSI in overbought range
- Price at immediate resistance level $145.75
- Decreasing volume indicating liquidity pressure
Medium Term
1–3 yearsPositive
Model confidence: 7/10
Key Factors
- Undervalued relative to DCF fair value
- Strong free cash flow and solid ROE
- Defensive consumer sector with low beta
Long Term
> 3 yearsPositive
Model confidence: 8/10
Key Factors
- Potential upside to fair value near $268
- Stable margins and modest revenue growth
- Diversified geographic footprint reducing concentration risk
Key Metrics & Analysis
Financial Health
Revenue Growth1.10%
Profit Margin5.58%
P/E Ratio11.2
ROE13.57%
ROA6.67%
Debt/Equity41.21
P/B Ratio1.4
Op. Cash Flow$206.0M
Free Cash Flow$151.8M
Technical Analysis
TrendNeutral
RSI66.2
Support$138.75
Resistance$145.75
MA 20$143.71
MA 50$143.79
MA 200$124.97
MACDBullish
VolumeDecreasing
Fear & Greed Index86.71
Valuation
Fair Value$268.22
GradeUndervalued
TypeValue
Risk Assessment
Beta0.02
Volatility12.05%
Sector RiskLow
Reg. RiskLow
Geo RiskMedium
Currency RiskMedium
Liquidity RiskHigh
Similar Tickers
This analysis may contain inaccuracies and is provided for informational and research purposes only. It is not personal investment advice, a recommendation, or an instruction to buy, sell, or hold any asset.